3Therasse P, Arbuck SG, Eisenhauer EA, et al. New guid-lines to evaluate the response to treatment in solid tumors [J]. J. National Cancer Institute, 2000,92 (3): 205-216.
4孙燕,周际昌.临床肿瘤内科手册[M].4版.北京:人民卫生出版社,2006:489.
5Glirnelius B, Hoffman K,Craf W,et al Quality of life during chemotherapy in patients with symptomatic ad- vanced cancer the nordic gastrointal tumor adjuvant therapy group [J]. Cancer,1994,73(3):556-562.
4Bamias A, Karina M, Papakostas P, et al. A randomized phase Ⅲ study of adjuvant platinum/docetaxel chemotherapy with or without radiation therapy in patients with gastric cancer [ J ]. Cancer Chemother Pharmacol, 2010,65(6) :1009 - 1021.
5Hoff PM, Ansari R, Batist G, et al. Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first - line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase Ⅲ study [J]. J Clin Oncol,2001,19(8) :2282 -2292.
6Macdonald JS, Smalley SR, Benedetti J, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction [ J ]. N Engl J Med,2001,345 (10) :725 - 730.
7Glimelius B, Hoffman K, Graf W, et al. Quality of life during chemotherapy in patients with symptomatic advanced colorectal cancer. The Nordic Gastrointestinal Tumor Adjuvant Therapy Group [J]. Cancer, 1994, 73(3) :556 -562.
8Pazdur R, Vincent M. Raltitrexed (Tomudex) versus 5-fluorouracil and leucovorin (5FU + LV) in patients with advanced colorectal cancer (ACC) : resuhs of a randomized, multicenter, North American trial [ C]. Denver:Proc Am Soc, 1997 :a801.
9Cocconi G, Cunningham D, Van Cutsem E, et al. Open, randomized, multicenter trial of raltitrexed versus fluorouracil plus high-dose leucovorin in patients with advanced colorectal cancer. Tomudex Colorectal Cancer Study Group [ J ]. J Clin Oncol, 1998, 16(9) : 2943 -2952.
10Cunningham D, Zalcberg JR, Rath U, et al. Final results of a randomised trial comparing Tomudex ( raltitrexed ) with 5-fluorouracil plus leucovorin in advanced colorectal cancer. 'Tomudex' Colorectal Cancer Study Group [J]. Ann Oncol, 1996, 7(9) : 961 - 965.
2Reni M, Balzano G, Aprile G, et al. Adjuvant PEFG( eisplatin, epirubi- cin ,5-fluorouracil, gemcitabine) or gemcitabine followed by chemora- diation in pancreatic cancer: a randomized phase Ⅱ trial [ J ]. Ann Surg Oncol, 2012,19 ( 7 ) : 2256 -2263.
3Seki A, Hori S. Switching the loaded agent from epirubicin to cispla- tin:salvage transcatheter arterial chemoembolization with drug-eluting microspheres for unresectable hepatocellular carcinoma [ J ]. Cadd In- terv Radio1,2012,35 ( 3 ) :555-562.
4Saimura M, Anan K, Mitsuyama S, et al. A multicenter study of epiru- bicin-docetaxel(ET) as primary chemotherapy for patients with in- flammatory breast cancer(IBC) [J]. Gan To Kagaku Ryoho,2012,39 (7) : 1075-1079.
